论文部分内容阅读
目的：探讨凝血酶原时间以及血小板检验用于肝硬化病人中的临床价值。方法：本次的研究对象为我院收治的98例肝硬化病人以及在我院进行健康体检的98例健康人员。其中98例肝硬化病人作为此次研究的肝硬化组，98例健康人员作为此次研究的健康组。肝硬化组与健康组的研究对象均为2019年3月－2020年3月期间在我院进行治疗或体检。对肝硬化组与健康组研究对象的血液进行取样后送检，记录对比肝硬化组与健康组的凝血酶原时间以及血小板参数。结果：与健康组对比，肝硬化组病人的凝血酶原时间更长（P<0.01），血小板计数更少（P<0.01），血小板平均体积更大（P<0.01），血小板体积分布宽度更广（P<0.01），血小板压积更小（P<0.01）。结论：肝硬化病人的凝血酶原时间以及血小板参数异于健康人员，凝血酶原时间以及血小板检验可以用于临床对肝硬化病症的诊断，具有临床应用价值。“,”Objective:To explore the clinical value of prothrombin time and platelet test in patients with liver cirrhosis. Methods:The subjects of this study are 98 patients with liver cirrhosis admitted to our hospital and 98 healthy people undergoing physical examinations in our hospital. Among them, 98 patients with liver cirrhosis were regarded as the cirrhosis group of this study, and 98 healthy persons were regarded as the healthy group of this study. The subjects of the liver cirrhosis group and the healthy group will be treated or examined in our hospital from March 2019 to March 2020. The blood of the subjects in the cirrhosis group and the healthy group was sampled and sent for examination, and the prothrombin time and platelet parameters of the cirrhosis group and the healthy group were recorded and compared. Results:Compared with the healthy group, patients in the cirrhosis group had longer prothrombin time (P<0.01), lower platelet count (P<0.01), larger average platelet volume (P<0.01), and wider platelet volume distribution (P<0.01). P<0.01), the platelet compaction is smaller (P<0.01). Conclusion:The prothrombin time and platelet parameters of patients with liver cirrhosis are different from those of healthy people. The prothrombin time and platelet test can be used in the clinical diagnosis of liver cirrhosis and have clinical application value.